Young Min Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Young Min Choi has a total of 248 co-authors. Here are the top co-authors by number of shared publications:
Shin Yong Moon
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea
45 shared publicationsSeok Hyun Kim
The Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
30 shared publicationsJung Gu Kim
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea
28 shared publicationsJin Ju Kim
Department of Obstetrics and Gynecology, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul 06236, Korea
24 shared publicationsKyu Ri Hwang
Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul 07061, Korea
15 shared publicationsSeung Yup Ku
The Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
15 shared publications
Latest Publications
- 28 February 2022
- Published by The Korean Data Analysis Society in Journal of The Korean Data Analysis Society
- Vol. 24 (1) , 329-343
Effect of Golf Course Service Quality on Customer Satisfaction, Reuse Intention and Recommendation Intention
- 28 February 2022
- Published by The Korean Data Analysis Society in Journal of The Korean Data Analysis Society
- Vol. 24 (1) , 329-343
Effect of Golf Course Service Quality on Customer Satisfaction, Reuse Intention and Recommendation Intention
- 13 January 2021
- Published by Wiley in Clinical Endocrinology
- Vol. 94 (5) , 837-844
Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study
Objective To investigate changes in glycemic status in women with polycystic ovary syndrome (PCOS) Design Longitudinal observational study Patients Women with PCOS who underwent baseline and follow‐up screening tests for diabetes (n=262). Four patients with type 2 diabetes (T2DM) at baseline and 6 patients who were taking drugs at the final follow‐up were excluded. Measurements Changes in glycemic classification based on fasting glucose, hemoglobin A1c and oral glucose tolerance test. Results The median length of follow‐up was 2.9 years. The mean age and body mass index in the normoglycemia group (n = 202) was 23.0 years and 21.6 kg/m2, while it was 23.6 years and 22.9 kg/m2 in the prediabetes group (n = 50). In the normoglycemia group, 38 (18.8%) and 2 (1.0%) developed prediabetes and T2DM, respectively. In the prediabetes group, 22 (44.0%) remained in the same category, 6 (12.0%) developed T2DM, while 22 (44.0%) achieved normoglycemia. The incidence rate of T2DM was 9.3 per 1,000 person‐years, which was significantly higher than that of the female population of similar age, and the incidence was higher in women with fasting glucose ≥ 5.6 mmol/L at baseline than in women with < 5.6 mmol/L. Conclusions About 20% of normoglycemic women had developed prediabetes or T2DM after a median time of 2.9 years. Meanwhile, nearly half of prediabetes women achieved normoglycemia. Higher baseline fasting glucose levels were associated with an increased incidence of T2DM. Our results are the first to evaluate glycemic status changes using all three parameters in PCOS patients.
- 13 January 2021
- Published by Wiley in Clinical Endocrinology
- Vol. 94 (5) , 837-844
Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study
Objective To investigate changes in glycemic status in women with polycystic ovary syndrome (PCOS) Design Longitudinal observational study Patients Women with PCOS who underwent baseline and follow‐up screening tests for diabetes (n=262). Four patients with type 2 diabetes (T2DM) at baseline and 6 patients who were taking drugs at the final follow‐up were excluded. Measurements Changes in glycemic classification based on fasting glucose, hemoglobin A1c and oral glucose tolerance test. Results The median length of follow‐up was 2.9 years. The mean age and body mass index in the normoglycemia group (n = 202) was 23.0 years and 21.6 kg/m2, while it was 23.6 years and 22.9 kg/m2 in the prediabetes group (n = 50). In the normoglycemia group, 38 (18.8%) and 2 (1.0%) developed prediabetes and T2DM, respectively. In the prediabetes group, 22 (44.0%) remained in the same category, 6 (12.0%) developed T2DM, while 22 (44.0%) achieved normoglycemia. The incidence rate of T2DM was 9.3 per 1,000 person‐years, which was significantly higher than that of the female population of similar age, and the incidence was higher in women with fasting glucose ≥ 5.6 mmol/L at baseline than in women with < 5.6 mmol/L. Conclusions About 20% of normoglycemic women had developed prediabetes or T2DM after a median time of 2.9 years. Meanwhile, nearly half of prediabetes women achieved normoglycemia. Higher baseline fasting glucose levels were associated with an increased incidence of T2DM. Our results are the first to evaluate glycemic status changes using all three parameters in PCOS patients.
- 26 November 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41 (7) , 1092-1096
The effects of luteinising hormone gene polymorphism on the outcomes of in vitro fertilisation and embryo transfer
Trp8Arg polymorphism of the LH beta gene has decreased bioactivity in vivo and previous studies showed conflicting data on the effect of LH beta gene polymorphism on the IVF outcome. In this study, 591 IVF patients were recruited. Patients with the variant allele(s) were the carrier group. In GnRH antagonist cycles, the clinical pregnancy rate was significantly lower in the carrier group (18.9%) than in the noncarrier group (37.1%). In long GnRH agonist cycles, the clinical pregnancy rate was comparable between both groups. To clarify the effect of COH protocols, IVF outcomes in the GnRH antagonist and long GnRH agonist protocol groups in carriers were analysed. Among carriers, the clinical pregnancy rate was significantly lower in the GnRH antagonist protocol group (18.9%) than in the long GnRH agonist protocol group (45.2%). Single nucleotide polymorphism analysis may contribute to the individualisation of COH protocols for each patient in the future.
- 26 November 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41 (7) , 1092-1096
The effects of luteinising hormone gene polymorphism on the outcomes of in vitro fertilisation and embryo transfer
Trp8Arg polymorphism of the LH beta gene has decreased bioactivity in vivo and previous studies showed conflicting data on the effect of LH beta gene polymorphism on the IVF outcome. In this study, 591 IVF patients were recruited. Patients with the variant allele(s) were the carrier group. In GnRH antagonist cycles, the clinical pregnancy rate was significantly lower in the carrier group (18.9%) than in the noncarrier group (37.1%). In long GnRH agonist cycles, the clinical pregnancy rate was comparable between both groups. To clarify the effect of COH protocols, IVF outcomes in the GnRH antagonist and long GnRH agonist protocol groups in carriers were analysed. Among carriers, the clinical pregnancy rate was significantly lower in the GnRH antagonist protocol group (18.9%) than in the long GnRH agonist protocol group (45.2%). Single nucleotide polymorphism analysis may contribute to the individualisation of COH protocols for each patient in the future.
- 30 October 2020
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (6) , 558-561
Association Between Polycystic Ovary Syndrome and the Polymorphisms of Aryl Hydrocarbon Receptor Repressor, Glutathione-S-transferase T1, and Glutathione-S-transferase M1 Genes
To investigate the association between the aryl hydrocarbon receptor repressor (AhRR) C/G polymorphisms and glutathione-S-transferase M1 (GSTM1) and GSTT1 null mutation and the risk of polycystic o... 目标:探讨韩国女性芳香烃受体抑制因子(AhRR)C/G多态性、谷胱甘肽-S-转移酶M1(GSTM1)和GSTT1无效突变与多囊卵巢综合征(PCOS)发病风险之间的关系。方法:这是一项病例对照研究, 纳入478名PCOS女性和376名年龄匹配的健康对照。AhRR C/G多态性和GSTM1、GSTT1基因分型分别采用实时荧光定量PCR和多重PCR进行分析。结果:AhRR C/G多态性和GSTM1...
- 30 October 2020
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (6) , 558-561
Association Between Polycystic Ovary Syndrome and the Polymorphisms of Aryl Hydrocarbon Receptor Repressor, Glutathione-S-transferase T1, and Glutathione-S-transferase M1 Genes
To investigate the association between the aryl hydrocarbon receptor repressor (AhRR) C/G polymorphisms and glutathione-S-transferase M1 (GSTM1) and GSTT1 null mutation and the risk of polycystic o... 目标:探讨韩国女性芳香烃受体抑制因子(AhRR)C/G多态性、谷胱甘肽-S-转移酶M1(GSTM1)和GSTT1无效突变与多囊卵巢综合征(PCOS)发病风险之间的关系。方法:这是一项病例对照研究, 纳入478名PCOS女性和376名年龄匹配的健康对照。AhRR C/G多态性和GSTM1、GSTT1基因分型分别采用实时荧光定量PCR和多重PCR进行分析。结果:AhRR C/G多态性和GSTM1...
- 1 September 2020
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 35 (9) , 2167-2169
Reply: Impact of the newly recommended antral follicle count cut-off for polycystic ovary in adult women with polycystic ovary syndrome
- 1 September 2020
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 35 (9) , 2167-2169
Reply: Impact of the newly recommended antral follicle count cut-off for polycystic ovary in adult women with polycystic ovary syndrome
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Korean Medical Science
- Vol. 35 (25) , e197
Successful Pregnancy and Delivery with Intracytoplasmic Sperm Injection in HIV-Serodiscordant Couple: the First Case in Korea
Seong JS, et al. J Korean Med Sci. 2020 May;35(25):e197. https://doi.org/10.3346/jkms.2020.35.e197
- 1 January 2020
- Published by XMLink in Journal of Korean Medical Science
- Vol. 35 (25) , e197
Open AccessSuccessful Pregnancy and Delivery with Intracytoplasmic Sperm Injection in HIV-Serodiscordant Couple: the First Case in Korea
Seong JS, et al. J Korean Med Sci. 2020 May;35(25):e197. https://doi.org/10.3346/jkms.2020.35.e197
- Open Access
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (3) , 268-278
Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
Shin JJ, et al. J Breast Cancer. 2019 Nov;23:e33. https://doi.org/10.4048/jbc.2020.23.e33
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (3) , 268-278
Open AccessEffect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
Shin JJ, et al. J Breast Cancer. 2019 Nov;23:e33. https://doi.org/10.4048/jbc.2020.23.e33
- 1 January 2020
- Published by Taylor & Francis in Human Fertility
- Vol. 25 (1) , 128-134
Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls
This study was performed to compare the prevalence of autoimmune thyroid disease (AITD) assessed by thyroid peroxidase antibody (anti-TPO Ab) and thyroid ultrasonography (USG) in Korean women with polycystic ovary syndrome (PCOS) (n = 210) and age-matched controls (n =343). We also compared the clinical features of women with PCOS according to the presence of AITD. Patients and controls were enrolled from a population who visited a screening centre for a general health check-up. There was no difference in the frequency of anti-TPO Ab positivity between the women with PCOS and the controls (4.8% (5/104) in patients and 7.6% (18/238) in controls). The frequency of heterogeneous or hypoechoic parenchyma on USG also did not differ between the patients and controls (9.3% (11/118) in patients and 12.3% (40/325) in controls). Within the PCOS group, the subjects with AITD (who had either Ab positivity or sonographic findings compatible with thyroiditis) showed significantly higher body mass indexes, waist circumferences and homeostasis model assessment for insulin resistance levels than the patients without AITD. In conclusion, AITD was not more prevalent in women with PCOS than in controls. However, among women with PCOS, subjects with AITD showed significantly higher adiposity and insulin resistance index than those without AITD.
- 1 January 2020
- Published by Taylor & Francis in Human Fertility
- Vol. 25 (1) , 128-134
Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls
This study was performed to compare the prevalence of autoimmune thyroid disease (AITD) assessed by thyroid peroxidase antibody (anti-TPO Ab) and thyroid ultrasonography (USG) in Korean women with polycystic ovary syndrome (PCOS) (n = 210) and age-matched controls (n =343). We also compared the clinical features of women with PCOS according to the presence of AITD. Patients and controls were enrolled from a population who visited a screening centre for a general health check-up. There was no difference in the frequency of anti-TPO Ab positivity between the women with PCOS and the controls (4.8% (5/104) in patients and 7.6% (18/238) in controls). The frequency of heterogeneous or hypoechoic parenchyma on USG also did not differ between the patients and controls (9.3% (11/118) in patients and 12.3% (40/325) in controls). Within the PCOS group, the subjects with AITD (who had either Ab positivity or sonographic findings compatible with thyroiditis) showed significantly higher body mass indexes, waist circumferences and homeostasis model assessment for insulin resistance levels than the patients without AITD. In conclusion, AITD was not more prevalent in women with PCOS than in controls. However, among women with PCOS, subjects with AITD showed significantly higher adiposity and insulin resistance index than those without AITD.
- 1 November 2019
- Published by Elsevier in Fertility and Sterility
- Vol. 112 (5) , 959-966.e1
Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values
- 1 November 2019
- Published by Elsevier in Fertility and Sterility
- Vol. 112 (5) , 959-966.e1
Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values
- 15 April 2019
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 39 (5) , 681-686
Arterial stiffness measured by cardio-ankle vascular index in Korean women with polycystic ovary syndrome
Many studies have reported an increased arterial stiffness using pulse wave velocity (PWV) in women with polycystic ovary syndrome (PCOS). However, PWV is essentially dependent on blood pressure (BP) at the time of measurement. The cardio-ankle vascular index (CAVI) is a relatively new index for measuring arterial stiffness, and its conspicuous feature is its independency from the BP at the time of measurement. The aim of this study was to evaluate arterial stiffness by CAVI in PCOS patients (n = 26) and in the age-matched controls (n = 59). The CAVI was measured by a single medical professional. The mean age of the women with PCOS was 33.3 (±6.6) years, and that of the matched controls was 33.1 (±5.9) years (p = .861). The mean CAVIs were similar between the patients and controls (6.49 ± 0.41 and 6.39 ± 0.65, respectively, p = .452). The CAVI increased linearly with age in both groups, but in the women with PCOS, CAVI showed relatively strong negative correlations with body mass index (BMI) in both the unadjusted (r = −0.537, p = .005) and adjusted models (r = −0.474, p = .003 after age and BMI adjustment and r = −0.604, p = .033 after age, BMI, sitting auscultatory systolic BP and square root hs-CRP adjustment). In conclusion, relatively young women with PCOS may not have increased arterial stiffness. A negative correlation between CAVI and BMI in women with PCOS requires further study to determine whether vascular adaptation to adiposity occurred in these women.
- 15 April 2019
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 39 (5) , 681-686
Arterial stiffness measured by cardio-ankle vascular index in Korean women with polycystic ovary syndrome
Many studies have reported an increased arterial stiffness using pulse wave velocity (PWV) in women with polycystic ovary syndrome (PCOS). However, PWV is essentially dependent on blood pressure (BP) at the time of measurement. The cardio-ankle vascular index (CAVI) is a relatively new index for measuring arterial stiffness, and its conspicuous feature is its independency from the BP at the time of measurement. The aim of this study was to evaluate arterial stiffness by CAVI in PCOS patients (n = 26) and in the age-matched controls (n = 59). The CAVI was measured by a single medical professional. The mean age of the women with PCOS was 33.3 (±6.6) years, and that of the matched controls was 33.1 (±5.9) years (p = .861). The mean CAVIs were similar between the patients and controls (6.49 ± 0.41 and 6.39 ± 0.65, respectively, p = .452). The CAVI increased linearly with age in both groups, but in the women with PCOS, CAVI showed relatively strong negative correlations with body mass index (BMI) in both the unadjusted (r = −0.537, p = .005) and adjusted models (r = −0.474, p = .003 after age and BMI adjustment and r = −0.604, p = .033 after age, BMI, sitting auscultatory systolic BP and square root hs-CRP adjustment). In conclusion, relatively young women with PCOS may not have increased arterial stiffness. A negative correlation between CAVI and BMI in women with PCOS requires further study to determine whether vascular adaptation to adiposity occurred in these women.